CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 45452-45781 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T227","span":{"begin":0,"end":329},"obj":"Sentence"}],"text":"Generation of this recombinant monoclonal human IgM marked an important step forward in the production of a potential therapeutic agent aimed at ameliorating demyelination in patients with MS, as this antibody is available in essentially unlimited quantities and will not induce crossspecies reactivity if administered to humans."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T227","span":{"begin":0,"end":329},"obj":"Sentence"},{"id":"TextSentencer_T227","span":{"begin":0,"end":329},"obj":"Sentence"},{"id":"T22751","span":{"begin":0,"end":329},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Generation of this recombinant monoclonal human IgM marked an important step forward in the production of a potential therapeutic agent aimed at ameliorating demyelination in patients with MS, as this antibody is available in essentially unlimited quantities and will not induce crossspecies reactivity if administered to humans."}

{"project":"Epistemic_Statements","denotations":[{"id":"T102","span":{"begin":0,"end":329},"obj":"Epistemic_statement"}],"text":"Generation of this recombinant monoclonal human IgM marked an important step forward in the production of a potential therapeutic agent aimed at ameliorating demyelination in patients with MS, as this antibody is available in essentially unlimited quantities and will not induce crossspecies reactivity if administered to humans."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T169","span":{"begin":189,"end":191},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Generation of this recombinant monoclonal human IgM marked an important step forward in the production of a potential therapeutic agent aimed at ameliorating demyelination in patients with MS, as this antibody is available in essentially unlimited quantities and will not induce crossspecies reactivity if administered to humans."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T90","span":{"begin":158,"end":171},"obj":"Phenotype"}],"attributes":[{"id":"A90","pred":"hp_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"Generation of this recombinant monoclonal human IgM marked an important step forward in the production of a potential therapeutic agent aimed at ameliorating demyelination in patients with MS, as this antibody is available in essentially unlimited quantities and will not induce crossspecies reactivity if administered to humans."}